The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Betz Stephen F. since 2021.
This trader's CIK number is 1886575.
At the time of last reporting, Betz Stephen F. was the Chief Scientific Officer of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX).
Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CRNX | 0 | $0 | 103,253 | $3,340,942 | 88,170 | $493,311 |
| 2024 | CRNX | 0 | $0 | 28,035 | $1,299,382 | 0 | $0 |
| 2023 | CRNX | 0 | $0 | 17,462 | $440,067 | 0 | $0 |
| 2022 | CRNX | 0 | $0 | 86,537 | $1,865,624 | 0 | $0 |
| 2021 | CRNX | 0 | $0 | 47,714 | $1,266,965 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-12 | CRNX | Option Ex | 88,170 | 5.59 | 493,311 |
| 2025-06-12 | CRNX | Sale | 97,483 | 32.23 | 3,141,877 |
| 2025-03-19 | CRNX | Sale | 5,770 | 34.50 | 199,065 |
| 2024-09-10 | CRNX | Sale | 1,035 | 51.50 | 53,302 |
| 2024-08-26 | CRNX | Sale | 3,000 | 53.19 | 159,570 |
| 2024-08-12 | CRNX | Sale | 3,000 | 47.68 | 143,040 |
| 2024-07-25 | CRNX | Sale | 3,000 | 53.43 | 160,290 |
| 2024-06-25 | CRNX | Sale | 3,000 | 45.37 | 136,110 |
| 2024-06-10 | CRNX | Sale | 3,000 | 43.86 | 131,580 |
| 2024-05-28 | CRNX | Sale | 3,000 | 47.49 | 142,470 |
| 2024-05-10 | CRNX | Sale | 3,000 | 49.43 | 148,290 |
| 2024-01-25 | CRNX | Sale | 3,000 | 37.26 | 111,780 |
| 2024-01-10 | CRNX | Sale | 3,000 | 37.65 | 112,950 |
| 2023-12-26 | CRNX | Sale | 3,000 | 35.89 | 107,670 |
| 2023-11-27 | CRNX | Sale | 3,000 | 31.84 | 95,520 |
| 2023-02-01 | CRNX | Sale | 3,126 | 19.59 | 61,238 |
| 2023-01-25 | CRNX | Sale | 8,336 | 21.07 | 175,639 |
| 2022-12-01 | CRNX | Sale | 3,126 | 17.84 | 55,767 |
| 2022-11-15 | CRNX | Sale | 3,126 | 18.72 | 58,518 |
| 2022-10-17 | CRNX | Sale | 3,126 | 17.73 | 55,423 |
| 2022-10-17 | CRNX | Sale | 3,126 | 17.73 | 55,423 |
| 2022-10-03 | CRNX | Sale | 3,126 | 19.64 | 61,394 |
| 2022-09-15 | CRNX | Sale | 4,168 | 21.01 | 87,569 |
| 2022-09-15 | CRNX | Sale | 4,168 | 21.01 | 87,569 |
| 2022-09-15 | CRNX | Sale | 4,168 | 21.01 | 87,569 |
| 2022-09-15 | CRNX | Sale | 4,168 | 21.01 | 87,569 |
| 2022-09-15 | CRNX | Sale | 4,168 | 21.01 | 87,569 |
| 2022-05-02 | CRNX | Sale | 3,247 | 20.10 | 65,251 |
| 2022-04-18 | CRNX | Sale | 5,664 | 25.81 | 146,187 |
| 2022-04-04 | CRNX | Sale | 9,000 | 23.97 | 215,766 |
| 2022-04-01 | CRNX | Sale | 4,164 | 21.80 | 90,775 |
| 2022-03-31 | CRNX | Sale | 4,164 | 21.06 | 87,698 |
| 2022-03-15 | CRNX | Sale | 3,123 | 18.94 | 59,149 |
| 2022-03-01 | CRNX | Sale | 3,123 | 19.73 | 61,616 |
| 2022-02-15 | CRNX | Sale | 3,123 | 18.64 | 58,212 |
| 2022-02-01 | CRNX | Sale | 3,123 | 18.79 | 58,681 |
| 2022-01-18 | CRNX | Sale | 4,168 | 23.29 | 97,072 |
| 2022-01-03 | CRNX | Sale | 7,168 | 28.02 | 200,847 |
| 2021-12-28 | CRNX | Sale | 3,000 | 27.95 | 83,853 |
| 2021-12-15 | CRNX | Sale | 5,668 | 24.14 | 136,825 |
| 2021-12-01 | CRNX | Sale | 5,668 | 27.38 | 155,189 |
| 2021-11-16 | CRNX | Sale | 1,500 | 27.97 | 41,955 |
| 2021-11-15 | CRNX | Sale | 5,668 | 26.75 | 151,619 |
| 2021-11-05 | CRNX | Sale | 12,600 | 27.95 | 352,195 |
| 2021-11-08 | CRNX | Sale | 3,900 | 28.42 | 110,845 |
| 2021-11-01 | CRNX | Sale | 5,668 | 24.79 | 140,509 |
| 2021-10-27 | CRNX | Sale | 3,000 | 24.00 | 71,991 |
| 2021-10-21 | CRNX | Sale | 1,042 | 21.10 | 21,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Betz Stephen F. (Chief Scientific Officer of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.